RESEARCH TRIANGLE PARK, N.C. - March 5, 2001 - Quintiles Transnational Corp. (Nasdaq: QTRN) today issued the following statement regarding U.S. District Court Judge Terrence W. Boyle's decision to deny WebMD's motion and leave in place a state court's order requiring WebMD to continue uninterrupted data delivery to Quintiles, pending his entry of a federal court temporary restraining order on Wednesday requiring WebMD to continue data delivery:
"We're very pleased with the result today," said John S. Russell, Senior Vice President and General Counsel, Quintiles Transnational Corp. "Both a state judge and a federal judge have said that Quintiles is entitled to an uninterrupted flow of data from WebMD.
"We are also pleased that Judge Boyle indicated that he would enter a temporary restraining order on Wednesday to continue the delivery of data to us. Although we don't know how his order will read, Judge Boyle indicated it would have the effect of encouraging the parties to resolve data delivery issues. We look forward to resolving these issues as soon as possible.
"We remain absolutely committed to patient privacy, as evidenced by more than a decade of maintaining confidentiality of records. Our business is to help build a better, more efficient healthcare system through swift delivery of de-identified, aggregated healthcare data."
Pharmaceutical companies, governments and healthcare organizations rely on the uninterrupted flow of these data for a variety of purposes, including public health screening; analyzing disease prevalence trends and treatment patterns; identification of disease "clusters" in geographic regions; and drug safety surveillance.
Quintiles Transnational is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve healthcare. Headquartered near Research Triangle Park, North Carolina, Quintiles employs a global workforce of 18,000 in 39 countries. Quintiles Transnational is a member of the S&P 500 and Fortune 1000. For more information visit the company's Web site at www.quintiles.com.
Information in this press release contains "forward-looking statements" about Quintiles. These statements involve risks and uncertainties that could cause actual results to differ materially, including without limitation, our ability to complete development and commercialization of new products, the cost and timing of bringing new products to market compared with revenues which may be generated by them, market acceptance, that the court may not grant our motion for a preliminary injunction or may do so on terms less favorable than we requested, our data products business remains subject to state and federal laws and regulations, and we continue to rely on compliance from WebMD under the Data Rights Agreement to supply us data. Additional factors that could cause actual results to differ materially, including with respect to data products, are discussed in the company's recent filings with the Securities and Exchange Commission, including but not limited to its S-3 and S-4 Registration Statements, its Annual Report on Form 10-K, its Form 8-Ks, and its other periodic reports, including Form 10-Qs.